Your browser doesn't support javascript.
loading
An Assessment of Ovarian Cancer Histotypes Across the African Diaspora.
George, Sophia H L; Omotoso, Ayodele; Pinto, Andre; Mustapha, Aisha; Sanchez-Covarrubias, Alex P; Umar, Usman Aliyu; Umar, Ali Bala; Oluwasola, Timothy Abiola; Okolo, Clement Abu; Anthony, Umeh Uchenna; Ukekwe, Francis Ikechukwu; Bakari, Maisaratu A; Dahiru, Aminu M C; Abdullahi, Habiba Ibrahim; Abimiku, Bawa Ahmed; Abdurrahman, Aisha; Usman, Asmau; Ahmed, Saad Aliyu; Usman, Hadiza Abdullahi; Kabir, Abba; Eleje, George Uchenna; Chiemeka, Michael Emeka; Nzeribe, Emily; Nweke, Ikechukwu; Kadas, SaiduAbubakar; Suleiman, Dauda E; Ekanem, Etim; Uche, Umemmuo Maureen; Paul, Jibrin; Agwu, Uzoma Maryrose; Edegbe, Felix O; Anorlu, Rose I; Banjo, Adekunbiola; Ajenifuja, Kayode Olusegun; Fawole, Adegboyega Adisa; Kazeem, Ibrahim O O; Magaji, Francis; Silas, Olugbenga; Athanasius, Boma Precious; Tamunomie, Nyengidiki Kennedy; Bassey, Emem; Abudu, Kunle; Ango, Ibrahim G; Abdullahi, Kabiru; Lawal, Ishak; Kabir, Suleiman Aliyu; Ekanem, Victor; Ezeanochie, Michael; Yahaya, Usman Rahman; Castillo, Melissa Nicole.
Afiliação
  • George SHL; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, United States.
  • Omotoso A; African Caribbean Cancer Consortium, Philadelphia, PA, United States.
  • Pinto A; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Mustapha A; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Sanchez-Covarrubias AP; Department of Pathology, University of Calabar Teaching Hospital, Calabar, Nigeria.
  • Umar UA; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Umar AB; Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, United States.
  • Oluwasola TA; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Okolo CA; Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
  • Anthony UU; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, United States.
  • Ukekwe FI; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Bakari MA; Department of Pathology, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Dahiru AMC; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Abdullahi HI; Department of Pathology, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Abimiku BA; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Abdurrahman A; Department of Obstetrics and Gynecology, Gynecological Oncology Unit, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Usman A; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Ahmed SA; Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Usman HA; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Kabir A; Department of Obstetrics and Gynecology and Department of Pathology, University of Nigeria Teaching Hospital Enugu, Enugu, Nigeria.
  • Eleje GU; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Chiemeka ME; Department of Obstetrics and Gynecology and Department of Pathology, University of Nigeria Teaching Hospital Enugu, Enugu, Nigeria.
  • Nzeribe E; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Nweke I; Department of Obstetrics and Gynecology and Department of Pathology, Federal Medical Center Yola, Yola, Nigeria.
  • Kadas S; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Suleiman DE; Department of Obstetrics and Gynecology and Department of Pathology, Federal Medical Center Yola, Yola, Nigeria.
  • Ekanem E; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Uche UM; Department of Obstetrics and Gynecology and Department of Pathology, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
  • Paul J; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Agwu UM; Department of Obstetrics and Gynecology and Department of Pathology, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
  • Edegbe FO; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Anorlu RI; Federal Medical Centre Katsina, Katsina, Nigeria.
  • Banjo A; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Ajenifuja KO; Federal Medical Centre Katsina, Katsina, Nigeria.
  • Fawole AA; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Kazeem IOO; Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
  • Magaji F; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Silas O; Department of Obstetrics and Gynecology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
  • Athanasius BP; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Tamunomie NK; Department of Obstetrics and Gynecology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
  • Bassey E; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Abudu K; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
  • Ango IG; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Abdullahi K; Department of Anatomic Pathology and Forensic Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
  • Lawal I; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Kabir SA; Department of Obstetrics and Gynecology and Department of Pathology, Federal Medical Center, Owerri, Nigeria.
  • Ekanem V; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Ezeanochie M; Department of Obstetrics and Gynecology and Department of Pathology, Federal Medical Center, Owerri, Nigeria.
  • Yahaya UR; Transatlantic Gynecologic Cancer Research Consortium, Bauchi, Nigeria.
  • Castillo MN; Department of Obstetrics and Gynecology and Department of Pathology, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Front Oncol ; 11: 732443, 2021.
Article em En | MEDLINE | ID: mdl-34900682
ABSTRACT

OBJECTIVE:

Ovarian cancer in Black women is common in many West African countries but is relatively rare in North America. Black women have worse survival outcomes when compared to White women. Ovarian cancer histotype, diagnosis, and age at presentation are known prognostic factors for outcome. We sought to conduct a preliminary comparative assessment of these factors across the African diaspora.

METHODS:

Patients diagnosed with ovarian cancer (all histologies) between June 2016-December 2019 in Departments of Pathology at 25 participating sites in Nigeria were identified. Comparative population-based data, inclusive of Caribbean-born Blacks (CBB) and US-born Blacks (USB), were additionally captured from the International Agency for Research on Cancer and Florida Cancer Data Systems. Histology, country of birth, and age at diagnosis data were collected and evaluated across the three subgroups USB, CBB and Nigerians. Statistical analyses were done using chi-square and student's t-test with significance set at p<0.05.

RESULTS:

Nigerians had the highest proportion of germ cell tumor (GCT, 11.5%) and sex-cord stromal (SCST, 16.2%) ovarian cancers relative to CBB and USB (p=0.001). CBB (79.4%) and USB (77.3%) women were diagnosed with a larger proportion of serous ovarian cancer than Nigerians (60.4%) (p<0.0001). Nigerians were diagnosed with epithelial ovarian cancers at the youngest age (51.7± 12.8 years) relative to USB (58.9 ± 15.0) and CBB (59.0± 13.0,p<0.001). Black women [CBB (25.2 ± 15.0), Nigerians (29.5 ± 15.1), and USB (33.9 ± 17.9)] were diagnosed with GCT younger than White women (35.4 ± 20.5, p=0.011). Black women [Nigerians (47.5 ± 15.9), USB (50.9 ± 18.3) and CBB (50.9 ± 18.3)] were also diagnosed with SCST younger than White women (55.6 ± 16.5, p<0.01).

CONCLUSION:

There is significant variation in age of diagnosis and distribution of ovarian cancer histotype/diagnosis across the African diaspora. The etiology of these findings requires further investigation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos